Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 9.31
-0.01 (-0.11%)
Aug 14, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 608.19 million as of August 14, 2026. Its market cap has increased by 125.81% in one year.
Market Cap
608.19M
Enterprise Value
460.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.31
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 608.19M, an increase of 679.67%. That is a compound annual growth rate of 45.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 608.19M | 16.36% |
| Dec 31, 2025 | 522.69M | 225.34% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.08B |
| Satellos Bioscience | 278.72M |
| Helix BioPharma | 137.48M |
| Eastwood Bio-Medical Canada | 106.77M |
| ME Therapeutics Holdings | 75.97M |
| NurExone Biologic | 44.67M |
| Sona Nanotech | 44.21M |
| MedMira | 42.10M |